Telo Genomics Corp.
TELO.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -43.95% | -21.83% | -7.59% | 29.47% | 57.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.97% | -10.32% | -4.49% | 11.53% | 22.37% |
| Operating Income | 22.97% | 10.32% | 4.49% | -11.53% | -22.37% |
| Income Before Tax | 23.97% | 10.67% | 4.86% | -11.16% | -22.36% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.97% | 10.67% | 4.86% | -11.16% | -22.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.97% | 10.67% | 4.86% | -11.16% | -22.36% |
| EBIT | 22.97% | 10.32% | 4.49% | -11.53% | -22.37% |
| EBITDA | 22.84% | 10.35% | 4.77% | -11.45% | -22.74% |
| EPS Basic | 32.28% | 22.35% | 19.77% | 3.01% | -11.22% |
| Normalized Basic EPS | 31.80% | 22.07% | 19.63% | 3.35% | -10.15% |
| EPS Diluted | 20.74% | 14.78% | 15.19% | -1.81% | -8.98% |
| Normalized Diluted EPS | 31.80% | 22.07% | 19.63% | 3.35% | -10.15% |
| Average Basic Shares Outstanding | 11.30% | 14.37% | 18.67% | 15.86% | 11.23% |
| Average Diluted Shares Outstanding | 11.30% | 14.37% | 18.67% | 15.86% | 11.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
